Earnings Alerts

Metropolitan Bank & Trust (MBT) Earnings: Strong 4Q Performance with 1.43% Non-Performing Loans Ratio and 13% Return on Equity

By February 20, 2025 No Comments
  • Metrobank’s non-performing loans (NPL) ratio for the fourth quarter stands at 1.43%.
  • The bank achieved a return on equity (ROE) of 13% in the same period.
  • Analyst recommendations for Metrobank include 19 buying, 1 holding, and 1 selling.

A look at Metropolitan Bank & Trust Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience2
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Metropolitan Bank & Trust Company’s long-term outlook, as reflected in the Smartkarma Smart Scores, indicates a positive stance for the institution. With solid scores in Dividend (4) and Growth (4), the bank seems poised for steady expansion and income generation. Additionally, a Value score of 3 suggests that the bank’s current market price may offer a reasonable investment opportunity. However, with a Resilience score of 2, there may be some concerns regarding the bank’s ability to withstand economic downturns. Momentum, coming in at 3, indicates a moderate level of market momentum for Metropolitan Bank & Trust.

Metropolitan Bank & Trust Company, a provider of commercial and investment banking services, is positioned favorably in terms of growth prospects and dividend payouts according to the Smartkarma Smart Scores. The bank engages in a range of financial activities such as borrowing, lending, trade finance, investment banking, and savings. While showing strength in certain areas like growth and dividends, investors may want to keep an eye on the bank’s resilience score, which suggests some vulnerability to economic shocks. Overall, Metropolitan Bank & Trust Company’s Smart Scores paint a picture of a banking institution with a sound foundation but with aspects that require careful monitoring.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars